Qube Research & Technologies Ltd
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 31 quarters, returned +2.9% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 54.8% of quarters (excess t = 1.48, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 2664 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| AAPL | $1.4B | | ADD |
| MSFT | $893M | | ADD |
| MU | $742M | | ADD |
| JPM | $726M | | ADD |
| LLY | $658M | | ADD |
| GOOGL | $627M | | TRIM |
| AMZN | $612M | | TRIM |
| GOOG | $590M | | ADD |
| AVGO | $580M | | TRIM |
| SNDK | $536M | | TRIM |
| V | $501M | | HOLD |
| MRVL | $436M | | ADD |
| META | $428M | | ADD |
| WBD | $421M | | ADD |
| CVX | $419M | | ADD |
| PH | $417M | | ADD |
| GE | $405M | | ADD |
| BAC | $400M | | ADD |
| GM | $398M | | ADD |
| COF | $396M | | ADD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.